Bone Biologics Corp
BBLG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.47M
Close$
$2.19
497.1% upside
Current Fair Value
497.1% upsideUndervalued by 497.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.47 Million |
|---|---|
| Enterprise Value | $-2,558,162.00 |
| Earnings per Share | $-2.65 |
| Beta | 0.5 |
| Outstanding Shares | 3,737,327 |
Return
| Return on Equity | -72.41% |
|---|---|
| Return on Assets | -64.06% |
| Return on Invested Capital | -75.33% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 3.11 |
| Price to Sales | - |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 26, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.45%▲ 1.20% |
|---|---|
| Total Invested | $35,705▲ 635.58% |
| Investors Holding | 30% |
About Bone Biologics Corp
2 employees
